Skip to main content
SpringerLink
Log in

How can bone turnover markers be best utilized for prediction of skeletal events in patients with solid tumors?

  • Practice Point
  • Published:

From Nature Clinical Practice Oncology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fohr B et al. (2003) Clinical review 165: Markers of bone remodeling in metastatic bone disease. J Clin Endocrinol Metab 88: 5059–5075

    Article  CAS  Google Scholar 

  2. Coleman RE (2002) The clinical use of bone resorption markers in patients with malignant bone disease. Cancer 94: 2521–2533

    Article  Google Scholar 

  3. Lipton A et al. (2001) Bone markers in the management of metastatic bone disease. Cancer Treat Rev 27: 181–185

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Assistant Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Cellular and Structural Biology and Director of Orthopedic Research at the University of Texas Health Science Center, San Antonio, TX, USA

    Gregory R Mundy

Authors
  1. Gregory R Mundy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gregory R Mundy.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Glossary

SKELETAL-RELATED EVENT

Pathologic bone fracture, spinal-cord compression, bone surgery or bone radiotherapy

ECOG PERFORMANCE STATUS

A 0 (fully active) to 5 (dead) scoring system to assess the wellbeing of cancer patients and their ability to perform ordinary tasks

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mundy, G. How can bone turnover markers be best utilized for prediction of skeletal events in patients with solid tumors?. Nat Rev Clin Oncol 2, 242–243 (2005). https://doi.org/10.1038/ncponc0167

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0167

  • Springer Nature Limited

This article is cited by

Search

Navigation